
Please try another search
Breaking News
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1062 | 989 | 973 | 1033 | 1364 | 1470 |
Fund Return | 6.17% | -1.12% | -2.73% | 1.08% | 6.4% | 3.93% |
Place in category | 371 | 510 | 719 | 427 | 259 | 199 |
% in Category | 45 | 62 | 79 | 60 | 51 | 80 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund C dist USD h | 16.71B | 2.03 | 3.36 | 4.59 | ||
Global Income Fund C div USD hedged | 16.71B | 2.03 | 3.37 | 4.60 | ||
JPI Global Income Fund A acc USD he | 16.71B | 1.95 | 3.33 | 3.70 | ||
JPI Global Income Fund A div USD he | 16.71B | 1.96 | 3.34 | 3.71 | ||
JPI Global Income Fund A mth USD he | 16.71B | 1.95 | 3.32 | 3.69 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund A2 | 6.42B | 7.33 | 5.11 | 7.17 | ||
World Healthscience Fund E2 | 2.1B | 7.24 | 4.59 | 6.64 | ||
LU1960219225 | 1.29B | 7.48 | 6.14 | - | ||
LU2112291526 | 723.79M | 7.35 | 5.12 | - | ||
World Healthscience Fund C2u | 377.11M | 7.12 | 3.81 | 5.84 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.18 | 738.21 | -6.45% | |
UnitedHealth | US91324P1021 | 7.09 | 525.05 | -2.85% | |
AbbVie | US00287Y1091 | 6.69 | 186.96 | -7.28% | |
J&J | US4781601046 | 6.25 | 153.24 | -4.12% | |
AstraZeneca | GB0009895292 | 5.08 | 10,238.0 | -5.27% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review